Therapeutic Advances in Chronic Disease

Scope & Guideline

Pioneering solutions for today's chronic health challenges.

Introduction

Welcome to the Therapeutic Advances in Chronic Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Therapeutic Advances in Chronic Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2040-6223
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationTHER ADV CHRONIC DIS / Ther. Adv. Chronic Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal "Therapeutic Advances in Chronic Disease" focuses on advancing the understanding and management of chronic diseases through innovative research and therapeutic strategies. It aims to publish high-quality studies that contribute to the evidence base for clinical practice and patient outcomes.
  1. Chronic Disease Management:
    The journal emphasizes research on the management of chronic diseases, including diabetes, cardiovascular diseases, and respiratory conditions, aiming to improve patient care and treatment strategies.
  2. Innovative Therapeutics:
    It publishes studies on novel therapeutic approaches, including pharmacological interventions, surgical techniques, and complementary therapies, to address chronic disease challenges.
  3. Real-World Evidence:
    The journal values real-world studies that provide insights into the effectiveness and safety of treatments in diverse populations, enhancing the relevance of findings to clinical practice.
  4. Multidisciplinary Approaches:
    Research integrating various disciplines, such as pharmacology, nutrition, psychology, and public health, is highlighted to foster comprehensive strategies for chronic disease management.
  5. Patient-Centered Research:
    There is a strong focus on patient preferences, experiences, and outcomes, ensuring that research is aligned with the needs and values of patients.
The journal has identified several emerging themes that are gaining traction, reflecting current trends and the evolving landscape of chronic disease research.
  1. Digital Health and Telemedicine:
    Research on the application of digital health technologies and telemedicine has surged, particularly in light of the COVID-19 pandemic, highlighting their role in chronic disease management.
  2. Patient-Centric Approaches:
    There is an increasing focus on understanding patient preferences and experiences, leading to studies that prioritize patient-centered care and shared decision-making.
  3. Biomarkers and Personalized Medicine:
    Emerging studies are focusing on the identification of biomarkers for disease progression and treatment response, paving the way for more personalized therapeutic strategies.
  4. Integration of Lifestyle Interventions:
    Research exploring the impact of lifestyle modifications, such as diet and exercise, on chronic disease outcomes is gaining popularity, emphasizing holistic management.
  5. Long COVID and Post-Acute Sequelae:
    The impact of COVID-19 on chronic disease management and the long-term sequelae of the virus are becoming critical areas of focus, reflecting the ongoing relevance of the pandemic.

Declining or Waning

Over recent years, certain themes within the journal have shown a decline in prominence, reflecting shifting priorities in chronic disease research and management.
  1. Epidemiological Studies:
    While still relevant, the frequency of purely epidemiological studies has decreased, possibly due to a growing focus on intervention-based and real-world evidence research.
  2. Traditional Pharmacological Approaches:
    Research centered solely on traditional pharmacological therapies has waned as the field shifts towards personalized medicine and integrative approaches that consider lifestyle and behavioral factors.
  3. Basic Science Research:
    There has been a noticeable reduction in the publication of basic science studies that do not directly relate to clinical applications or therapeutic advancements.

Similar Journals

PANMINERVA MEDICA

Bridging research and practice for a healthier tomorrow.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0031-0808Frequency: 4 issues/year

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.

Pulmonary Therapy

Shaping the future of pulmonary therapy, one study at a time.
Publisher: SPRINGERNATUREISSN: 2364-1754Frequency: 2 issues/year

Pulmonary Therapy is a leading open-access journal published by SpringerNature, dedicated to advancing the field of pulmonary and respiratory medicine as well as respiratory care. Established in 2015 and situated in the United Kingdom, the journal has rapidly gained recognition, evidenced by its impressive Q2 quartile rankings in both the Pulmonary and Respiratory Medicine and Respiratory Care categories as of 2023. With a focus on innovative research, the journal provides a platform for the dissemination of high-quality studies that address critical issues in respiratory health. Leveraging the open access model, it ensures wide dissemination and accessibility of knowledge amongst researchers, healthcare professionals, and students, thereby fostering collaborative advancements in treatment approaches and preventive care strategies. As the field continues to evolve, Pulmonary Therapy remains committed to publishing impactful scientific contributions that shape the future of respiratory medicine.

HEPATOLOGY RESEARCH

Pioneering studies that transform the landscape of Hepatology.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

Postepy Higieny I Medycyny Doswiadczalnej

Empowering researchers with vital insights into health challenges.
Publisher: POLISH ACAD SCIENCES, INST IMMUNOL & EXP THERAPYISSN: 0032-5449Frequency: 1 issue/year

Postepy Higieny i Medycyny Doświadczalnej, published by the Polish Academy of Sciences, Institute of Immunology and Experimental Therapy, is a prominent academic journal dedicated to the fields of hygiene, experimental medicine, and infectious diseases. With a rich publication history dating back to 1949 and transitioned to Open Access since 2004, the journal aims to disseminate high-quality research and innovative findings that address urgent health challenges. Despite its recent Q4 categorization in various medical disciplines including Infectious Diseases and Microbiology, this journal remains a vital resource for researchers and practitioners seeking to navigate and contribute to the evolving landscape of medical science. The journal not only serves as a platform for significant scholarly work but also engages actively in the discourse surrounding public health in Poland and beyond. For those invested in advancing knowledge in the medical field, Postepy Higieny i Medycyny Doświadczalnej promises to be an essential addition to their academic resources.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Advancing Medical Research for Global Impact
Publisher: ELSEVIER TAIWANISSN: 0929-6646Frequency: 1 issue/year

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

Rational Pharmacotherapy in Cardiology

Exploring the Synergy of Cardiology and Rational Drug Use
Publisher: SOC CARDIOLOGY RUSSIAN FEDERATISSN: 1819-6446Frequency: 6 issues/year

Rational Pharmacotherapy in Cardiology, published by the SOC CARDIOLOGY RUSSIAN FEDERATION, stands as a crucial platform for advancing knowledge in the field of cardiology and pharmacology. Established as an Open Access journal in 2005, it allows for unrestricted access to research findings, fostering collaboration among researchers, clinicians, and students. The journal, with its ISSN 1819-6446 and E-ISSN 2225-3653, focuses on the intersection of rational pharmacotherapy and cardiovascular medicine, aiming to enhance treatment strategies and patient outcomes through evidence-based studies. Though currently positioned in the Q4 category in both cardiology and pharmacology rankings, its ongoing commitment to rigorous peer review and scholarly research ensures its relevance and growth in the scientific community. With a unique address in Moscow, Russia, the journal seeks to serve as a valuable resource for those dedicated to improving cardiovascular health and therapeutic practices worldwide, making it an essential read for professionals keen on the latest trends and discoveries in this vital area of medicine.

JOURNAL OF CLINICAL INVESTIGATION

Exploring the frontiers of human disease understanding.
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: 0021-9738Frequency: 12 issues/year

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

Internal Medicine

Elevating Knowledge in Internal Medicine
Publisher: JAPAN SOC INTERNAL MEDICINEISSN: 0918-2918Frequency: 12 issues/year

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

Aging and Disease

Exploring the intersection of longevity and health.
Publisher: INT SOC AGING & DISEASEISSN: 2152-5250Frequency: 6 issues/year

Aging and Disease is a leading open-access journal published by the International Society on Aging and Disease, dedicated to advancing the understanding of aging and its associated diseases. Since its inception in 2010, the journal has established itself as a vital resource for researchers and practitioners in the fields of Geriatrics, Neurology, Cell Biology, and Pathology. With an impressive Q1 ranking across multiple categories and a robust position in Scopus rankings, including ranks in the top 3% in Geriatrics and Gerontology, it showcases high-quality research that addresses the complexities of aging processes. Each issue presents original articles, reviews, and insights aimed at improving health outcomes for the aging population. The open-access model ensures that valuable research findings are readily available to a global audience, fostering collaboration and innovation. As a go-to publication for scholars, healthcare professionals, and students, Aging and Disease significantly contributes to the multidisciplinary dialogue surrounding aging and its health implications.

Pulmonology

Advancing lung health through groundbreaking research.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.